AU2566092A - Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines - Google Patents

Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines

Info

Publication number
AU2566092A
AU2566092A AU25660/92A AU2566092A AU2566092A AU 2566092 A AU2566092 A AU 2566092A AU 25660/92 A AU25660/92 A AU 25660/92A AU 2566092 A AU2566092 A AU 2566092A AU 2566092 A AU2566092 A AU 2566092A
Authority
AU
Australia
Prior art keywords
chimeras
vaccines
proteins
virus type
parainfluenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25660/92A
Inventor
Lydia Blaise
Alex Bollen
Dirk Gheysen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2566092A publication Critical patent/AU2566092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0065Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU25660/92A 1991-09-23 1992-09-18 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines Abandoned AU2566092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9120221 1991-09-23
GB919120221A GB9120221D0 (en) 1991-09-23 1991-09-23 Novel compounds

Publications (1)

Publication Number Publication Date
AU2566092A true AU2566092A (en) 1993-04-27

Family

ID=10701826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25660/92A Abandoned AU2566092A (en) 1991-09-23 1992-09-18 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines

Country Status (6)

Country Link
AU (1) AU2566092A (en)
GB (1) GB9120221D0 (en)
MX (1) MX9205367A (en)
PT (1) PT100885A (en)
WO (1) WO1993006218A2 (en)
ZA (1) ZA927199B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU663489B2 (en) * 1991-02-06 1995-10-12 Genetics Institute, Llc Peptide and protein fusions to thioredoxin and thioredoxin-like molecules

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723130A (en) 1993-05-25 1998-03-03 Hancock; Gerald E. Adjuvants for vaccines against respiratory syncytial virus
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
FR2726471B1 (en) * 1994-11-07 1997-01-31 Pf Medicament PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
BR9610590A (en) * 1995-09-22 2000-10-24 Connaught Lab Parainfluenza virus glycoproteins and vaccines
US6830748B1 (en) 1997-09-26 2004-12-14 Medimmune Vaccines, Inc. Recombinant RSV virus expression systems and vaccines
JP5796011B2 (en) 2009-06-24 2015-10-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム vaccine
CN104513317B (en) * 2013-09-30 2018-12-14 普莱柯生物工程股份有限公司 A kind of vaccine composition and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169628A (en) * 1988-04-22 1992-12-08 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU663489B2 (en) * 1991-02-06 1995-10-12 Genetics Institute, Llc Peptide and protein fusions to thioredoxin and thioredoxin-like molecules

Also Published As

Publication number Publication date
ZA927199B (en) 1993-06-14
PT100885A (en) 1993-11-30
GB9120221D0 (en) 1991-11-06
WO1993006218A2 (en) 1993-04-01
MX9205367A (en) 1993-03-01
WO1993006218A3 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
AU7865591A (en) Method and means for extending the host range of insecticidal proteins
AU640774B2 (en) Hair-treating microemulsion composition and method of preparing and using the same
ZA931613B (en) Conditioning shampoo composition and method of preparing and using the same
AU6017194A (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
AU1081292A (en) New beta-amino- alpha-hydroxycarboxylic acids and their use
AU2170592A (en) Protein compositions having reduced-hygroscopic properties and methods for preparing same
AU8806191A (en) Preparation of alkoxyalkanoic acids
AU2065992A (en) Herbicidal compositions and methods of preparing and using the same
AU8684991A (en) Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives
AU2566092A (en) Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
AU4013495A (en) Chemokine-like proteins and methods of use
AU2850492A (en) Novel aminoalkanephosphinic acids and salts thereof
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
GB9023149D0 (en) Proteins and nucleic acids
EP0536960A3 (en) Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes
ZA918863B (en) Substituted amino acid derivatives their preparation and use
AU586299B2 (en) Vaccine against mumps and process for its preparation
AU630186B2 (en) Canine corona virus vaccine
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
AU2968892A (en) Vaccines based on modified type 1 bovine herpesviruses
ZA917518B (en) Substituted amino acid derivatives their preparation and use
NZ224862A (en) Taenia ovis antigens and vaccines
GB9105446D0 (en) Proteins and nucleic acids